Cardiol Therapeutics (CRDL) Institutional Ownership → I’m officially sounding the alarm. (From Altimetry) (Ad) Free CRDL Stock Alerts $1.67 0.00 (-0.26%) (As of 09:40 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Cardiol Therapeutics (NASDAQ:CRDL)CurrentInstitutional OwnershipPercentage12.49%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$1.56MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$581.23K Get CRDL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cardiol Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRDL Institutional Buying and Selling by Quarter Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Cardiol Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024AdvisorShares Investments LLC1,189,978$1M0.2%-1.3%1.821% 2/9/2024AXS Investments LLC697,651$579K0.1%-9.8%1.068% 11/15/2023Tejara Capital Ltd645,457$578K0.3%+29.9%0.996% 11/15/2023Laird Norton Trust Company LLC100,000$90K0.0%+63.1%0.154% 11/13/2023Tejara Capital Ltd645,457$578K0.4%+29.9%0.996% 11/6/2023AdvisorShares Investments LLC1,205,788$1.11M0.3%-1.1%1.861% Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/10/2023FNY Investment Advisers LLC33,305$30K0.0%N/A0.051% 8/21/2023Osaic Holdings Inc.66,800$59K0.0%+81.5%0.104% 8/15/2023Royal Bank of Canada38,721$34K0.0%-26.4%0.060% 8/11/2023Tejara Capital Ltd497,061$442K0.2%+12.8%0.775% 8/10/2023Osaic Holdings Inc.66,800$59K0.0%+81.5%0.104% 8/10/2023AXS Investments LLC1,299,076$1.16M0.3%-24.8%2.026% 8/9/2023AdvisorShares Investments LLC1,219,738$1.09M0.3%+3.4%1.902% 8/2/2023Bank of Montreal Can112,179$110K0.0%N/A0.175% 7/13/2023Cambridge Investment Research Advisors Inc.76,611$68K0.0%+66.5%0.120% 5/16/2023Susquehanna International Group LLP106,477$52K0.0%N/A0.166% 5/12/2023Bank of America Corp DE60,500$29K0.0%N/A0.094% 5/12/2023AXS Investments LLC1,727,827$844K0.3%N/A2.698% 5/11/2023MMCAP International Inc. SPC3,153,400$1.54M0.3%-6.0%4.924% 5/9/2023AdvisorShares Investments LLC1,179,738$575K0.2%+7.2%1.842% 2/15/2023Jane Street Group LLC63,073$32K0.0%N/A0.098% 2/15/2023Tejara Capital Ltd440,626$225K0.1%N/A0.687% 2/10/2023Advisor Group Holdings Inc.74,710$38K0.0%+227.1%0.117% 2/9/2023Mirae Asset Global Investments Co. Ltd.1,094,040$557K0.0%+25.7%1.708% 2/1/2023Bank of Montreal Can90,000$61K0.0%+511.0%0.141% 11/15/2022Two Sigma Advisers LP35,900$37K0.0%-42.6%0.056% 8/15/2022MMCAP International Inc. SPC3,353,400$4.43M0.4%+3.1%5.414% 8/11/2022Marble Harbor Investment Counsel LLC38,150$50K0.0%+32.0%0.062% 8/2/2022Thompson Davis & CO. Inc.28,400$37K0.0%N/A0.046% 7/26/2022Mirae Asset Global Investments Co. Ltd.1,356,620$1.78M0.0%-2.3%2.190% 6/2/2022Mirae Asset Global Investments Co. Ltd.1,388,836$2.15M0.0%+32.9%2.243% 5/17/2022Jane Street Group LLC36,576$57K0.0%-30.7%0.059% 5/17/2022Royal Bank of Canada35,214$54K0.0%+66.2%0.057% 5/16/2022Goldman Sachs Group Inc.65,600$100K0.0%-48.0%0.106% 5/16/2022Vident Investment Advisory LLC126,157$195K0.0%+139.6%0.204% 5/11/2022MMCAP International Inc. SPC3,253,400$4.98M0.3%+3.2%7.294% 5/4/2022Advisor Group Holdings Inc.113,058$173K0.0%+2,240.7%0.253% 2/9/2022MMCAP International Inc. SPC3,153,200$5.83M0.4%N/A7.069% 1/25/2022Private Ocean LLC20,651$38K0.0%+275.5%0.046% 1/11/2022Brookstone Capital Management15,887$27K0.0%N/A0.036% Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story11/12/2021Renaissance Technologies LLC144,900$598K0.0%N/A0.334% 11/12/2021Vident Investment Advisory LLC50,566$208K0.0%N/A0.117% 11/10/2021Marble Harbor Investment Counsel LLC22,000$91K0.0%N/A0.051% 11/5/2021Advisor Group Holdings Inc.15,800$65K0.0%N/A0.036% (Data available from 1/1/2016 forward) CRDL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRDL shares? During the previous two years, 20 institutional investors and hedge funds held shares of Cardiol Therapeutics. The most heavily invested institutionals were MMCAP International Inc. SPC ($1.54M), AdvisorShares Investments LLC ($1M), AXS Investments LLC ($579K), Tejara Capital Ltd ($578K), Mirae Asset Global Investments Co. Ltd. ($557K), Vident Investment Advisory LLC ($195K), and Bank of Montreal Can ($110K).Learn more on CRDL's institutional investors. What percentage of Cardiol Therapeutics stock is owned by institutional investors? 12.49% of Cardiol Therapeutics stock is owned by institutional investors. Learn more on CRDL's institutional investor holdings. Which institutional investors have been buying Cardiol Therapeutics stock? Of the 18 institutional investors that purchased Cardiol Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AXS Investments LLC ($1.73M), Tejara Capital Ltd ($793.85K), Mirae Asset Global Investments Co. Ltd. ($567.11K), MMCAP International Inc. SPC ($200.20K), Bank of Montreal Can ($187.45K), Advisor Group Holdings Inc. ($160.10K), and AdvisorShares Investments LLC ($118.95K). How much institutional buying is happening at Cardiol Therapeutics? Institutional investors have bought a total of 4,273,293 shares in the last 24 months. This purchase volume represents approximately $3.15M in transactions. Which Cardiol Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cardiol Therapeutics stock in the last 24 months: AXS Investments LLC ($504.64K), MMCAP International Inc. SPC ($200K), Goldman Sachs Group Inc. ($60.50K), Mirae Asset Global Investments Co. Ltd. ($32.22K), AdvisorShares Investments LLC ($29.76K), Two Sigma Advisers LP ($26.60K), and Jane Street Group LLC ($16.22K). How much institutional selling is happening at Cardiol Therapeutics? Institutional investors have sold a total of 883,836 shares in the last 24 months. This volume of shares sold represents approximately $768.53K in transactions. Related Companies: OTLK Major Shareholders VIGL Major Shareholders LIFE Major Shareholders BLUE Major Shareholders BCAB Major Shareholders ZURA Major Shareholders AGEN Major Shareholders OMGA Major Shareholders DBVT Major Shareholders SGMO Major Shareholders This page (NASDAQ:CRDL) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden’s $374B Giveaway Into This SectorDTIThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.